Data From Takeda’s Narcolepsy Type 1 Studies Demonstrating Improved Symptoms
Just announced from Takeda: New England Journal of Medicine Publishes Data from Phase 3 Studies...
Just announced from Takeda: New England Journal of Medicine Publishes Data from Phase 3 Studies...
Just announced from the Lasker Foundation: Lasker Foundation Announces 2026 Lasker Award Winners (New York, September...
Just announced from Alkermes: The Lancet Neurology Publishes Data From Alkermes’ Positive Vibrance-1 Phase 2...
Wake Up Narcolepsy Executive Director, Tammy Anderson, attended the Society for Women's Health Research (SWHR)...
Just announced from Takeda Pharmaceuticals: ORZEYFUL (oveporexton) Approved in Japan as the First and Only Medicine...
Just announced from Lupin Limited: Lupin Announces Approval from U.S. FDA for Pitolisant Tablets Mumbai, Naples,...
Just announced from Takeda Pharmaceuticals: U.S. FDA Approves Takeda’s ORZEYFUL™ (oveporexton), the First and Only...
FDA News Release: August 05, 2026 - The U.S. Food and Drug Administration today...
Join clinical, industry, and community experts for a hybrid educational event where lived experience meets...
Back in September, Wake Up Narcolepsy (WUN) announced another partnership with the American Academy of...